⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31170709 | 1.00 | — | — | |
| SCHEMBL31170695 | 1.00 | — | — | |
| SCHEMBL25602783 | 1.00 | — | — | |
| SCHEMBL20066217 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28964877 | 0.98 | GABRR1 (0.54) | — | |
| Hydrochloric Acid SCHEMBL29025230 | 0.83 | GABRR1 (0.42) | — | |
| SCHEMBL2966759 | 0.80 | — | — | |
| SCHEMBL8144961 | 0.80 | — | — | |
| SCHEMBL14087163 | 0.80 | — | — | |
| SCHEMBL2966762 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712961-A2 | KRAS G12S AND G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238633-A2 | KRAS G12S AND G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2024-11-21 | — | — | WO | disclosed |